Vyvgart - direct healthcare professional communication (DHPC)

efgartigimod alfa

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : Vyvgart 1,000 mg solution for injection (efgartigimod alfa): requirement to visually inspect vials from certain batches due to risk of contamination

Key facts

• Medicine name:
  Vyvgart
• Active substance:
  efgartigimod alfa
• Therapeutic area (MeSH):
  • Myasthenia Gravis
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
• DHPC type:
  Quality defect
• Human ATC codes:
  L04AA58
• Dissemination date:
  23/07/2026